Skip to main content
. 2022 Oct 15;14(10):2265. doi: 10.3390/v14102265

Figure 2.

Figure 2

Amplification assays using RNA preparations from CtaHVd-LR1-positive (isolate 14A in 2018) and -negative (14O) samples and primer pairs CH1Rev/CH2For (left). CH3Rev/CH4F (middle) or CH5Rev/CH6F (right); C, negative control in which ddH2O instead of cDNA was added to the amplification mix; M, molecular marker is a 100 bp DNA ladder.